A lab technician works during research on coronavirus at Johnson & Johnson subsidiary Janssen Pharmaceutical in Beerse, Belgium, Wednesday, June 17, 2020. (Virginia Mayo/AP Images)

End­points News ranks the top 57 play­ers in the Covid-19 vac­cine race. Here's how it stacks up to­day

(This piece was last up­dat­ed on Oc­to­ber 29. End­points News will con­tin­ue to track the lat­est de­vel­op­ments through the FDA’s mar­ket­ing de­ci­sions.)

The 57 top play­ers now in or close to the clin­i­cal race to get a Covid-19 vac­cine over the fin­ish line are an­gling for a piece of a multi­bil­lion-dol­lar mar­ket. And be­ing among the lead­ers now be­hind Pfiz­er/BioN­Tech and Mod­er­na will play a big role in de­ter­min­ing just how big a piece.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.